Bliss GVS Pharma Ltd Half Yearly Results

Gross Sales

401.32

398.85

371.4

390.5

361.09

Excise Duty

0

0

0

0

0

Net Sales

401.32

398.85

371.4

390.5

361.09

Other Operating Income

0

0

0

0

0

Other Income

9.16

11.02

17.72

8.62

9.16

Total Income

410.48

409.87

389.11

399.12

370.25

Total Expenditure

325.51

356

292.82

336.57

297.7

PBIDT

84.97

53.87

96.3

62.55

72.56

Interest

5.36

3.97

2.94

6.35

4.02

PBDT

79.61

49.9

93.36

56.21

68.54

Depreciation

13.83

13.8

12.58

9.52

9.15

Minority Interest Before NP

0

0

0

0

0

Tax

19.72

16.18

17.08

19.34

21.51

Deferred Tax

-1.74

-4.25

6.28

-5.91

-5.6

Reported Profit After Tax

47.8

24.16

57.42

33.25

43.48

Minority Interest After NP

2.84

5.7

0.43

1.97

3.91

Net Profit after Minority Interest

44.96

18.46

56.99

31.29

39.57

Extra-ordinary Items

0

-29.2

0

0

0

Adjusted Profit After Extra-ordinary item

44.96

47.66

56.99

31.29

39.57

EPS (Unit Curr.)

4.28

1.76

5.47

3

3.81

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

10.51

10.47

10.44

10.42

10.37

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

21.17

13.5

25.92

16.01

20.09

PBDTM(%)

-

-

-

-

-

PATM(%)

11.91

6.05

15.46

8.51

12.04